Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-15, Stock:LLY, The news for the past five days is as follows:
2020-06-08: NEWS1: Eli Lilly (LLY) Flat As Market Gains: What You Should Know.NEWS2: Coronavirus update: Global death tally tops 400,000; health experts urge police to stop using tear gas on anti-racism protesters.NEWS3: Eli Lilly Kicks Off a Clinical Trial for a Second COVID-19 Antibody Treatment.NEWS4: Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication.NEWS5: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS6: Lilly to Participate in Goldman Sachs Global Healthcare Conference.NEWS7: Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment.NEWS8: Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial.
2020-06-09: NEWS1: 1972+1974=2020.NEWS2: Tuesday Morning Market Highlights.NEWS3: Lilly's 2nd Potential Coronavirus Antibody Candidate in Phase I.NEWS4: EXPLAINER-What are antibody therapies and who is developing them for COVID-19?.NEWS5: Hexo Corp. (HEXO) to Post Q3 Earnings: What's in the Offing?.NEWS6: First patient dose delivered for Lilly's tirzepatide cardiovascular outcomes trial.NEWS7: EXPLAINER-What are antibody therapies and who is developing them for COVID-19?.NEWS8: EXPLAINER-What are antibody therapies and who is developing them for COVID-19?.
2020-06-10: NEWS1: US STOCKS-S&P 500, Dow finish lower in volatile trade on dour Fed forecasts.NEWS2: ESG Investing Trend to Stay Strong Post Pandemic: 5 Top Picks.NEWS3: Lilly Begins Cardiovascular Outcomes Study on Tirzepatide.NEWS4: Here's the Surprising Coronavirus Stock You'll Really Want to Watch Right Now.
2020-06-11: NEWS1: Coronavirus update: US reopening dogged by fears of new wave as pharma presses on with vaccine.NEWS2: AbbVie Inks Deal With Genmab, Announces ADC Candidate Data.NEWS3: Regeneron Begins Human Trials of a Potential COVID-19 Treatment.NEWS4: Company News for Jun 11, 2020.NEWS5: Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist.
2020-06-12: NEWS1: Biotech Stocks Run Up In Coronavirus Drug Race, But Here's Another Way To Buy.NEWS2: Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life.NEWS3: Lilly Highlights the Evolution of Its Dermatology Portfolio at Annual American Academy of Dermatology Meeting (AAD).NEWS4: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS5: Lilly Partners with Indianapolis Recorder Newspaper, Radio One and WISH-TV for a Day of Solidarity Virtual Event.NEWS6: Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals.NEWS7: COVID-19 cases surge, officials issue warnings.NEWS8: J&J exec: Our coronavirus vaccine is aiming for a 70% success rate in trials.

Answer: Decrease